P. Devoto

发表

On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?

G. Flore, P. Devoto, Giovanna Flore, 2006, Current neuropharmacology.

Biochemical and electrophysiological effects of 7‐OH‐DPAT on the mesolimbic dopaminergic system

M. Pistis, M. Collu, G. Gessa, 1995, Synapse.

The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients

P. Calabresi, Qin Li, E. Bézard, 2019, Scientific Reports.

Failure by tricyclic antidepressants to affect the increase of dopamine extracellular concentrations produced by haloperidol in the caudate and accumbens nuclei of rats.

P. Devoto, A. Tagliamonte, G. D. De Montis, 1992, Biochemical pharmacology.

Inhibition of [3H]dopamine uptake by flunarizine.

P. Devoto, A. Kuzmin, L. Pani, 1991, European journal of pharmacology.

Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex

G. Gessa, G. Flore, P. Devoto, 2003, Synapse.

The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia

M. Pistis, R. Frau, M. Melis, 2018, CNS neuroscience & therapeutics.

Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson’s disease patients carrying the LRRK2 G2019S mutation

C. Missale, J. Schwamborn, C. Fiorentini, 2020, Neurobiology of Aging.

Sodium-dependent interaction of benzamides with dopamine receptors

P. Devoto, R. Collu, E. Stefanini, 1980, Brain Research.

The Implication of Neuroactive Steroids in Tourette's Syndrome Pathogenesis: A Role for 5α‐Reductase?

F. Marrosu, R. Frau, M. Bortolato, 2013, Journal of neuroendocrinology.

Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390

P. Devoto, A. Porcella, P. Saba, 1989, Journal of neuroscience research.

The potent α2-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride

G. Gessa, R. Frau, P. Devoto, 2022, Neuropharmacology.

Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT 2A receptor activation

S. Scheggi, C. Gambarana, B. Wilkinson, 2020 .

Antipsychotic-Like Properties of 5-α-Reductase Inhibitors

F. Marrosu, G. Gessa, R. Frau, 2008, Neuropsychopharmacology.

Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats

J. Cheer, R. Frau, M. Melis, 2020, bioRxiv.

Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by 1 pregnenolone 2 3

I. Katona, J. Cheer, R. Frau, 2019 .

Biochemical characterization of the dopaminergic innervation of the rat septum.

A. Argiolas, P. Devoto, R. Collu, 1980, Life sciences.

In utero exposure to methadone produces a stable decrease of the cortex 5-HT transport system in rats.

P. Devoto, A. Tagliamonte, G. D. De Montis, 1983, European journal of pharmacology.

Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants.

G. Gessa, G. Serra, P. Devoto, 1990, European journal of pharmacology.

Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis.

G. Flore, W. Fratta, P. Devoto, 2001, Toxicology letters.

Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex

G. Gessa, G. Flore, P. Devoto, 2012, Psychopharmacology.

Naloxone antagonizes ethanol- but not α-hydroxybutyrate-induced sleep in mice

G. Gessa, G. Colombo, P. Devoto, 1994 .

Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus

G. Gessa, M. Fà, G. Flore, 2005, BMC Neuroscience.

Isolation rearing-induced reduction of brain 5α-reductase expression: Relevance to dopaminergic impairments

F. Marrosu, M. Barbaccia, V. Cuomo, 2011, Neuropharmacology.

Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone

I. Katona, J. Cheer, R. Frau, 2019, Nature Neuroscience.

Sleep deprivation increases dopamine D1 receptor antagonist [3H]SCH 23390 binding and dopamine-stimulated adenylate cyclase in the rat limbic system

W. Fratta, P. Devoto, M. Martellotta, 1990, Neuroscience Letters.

Selective inhibition of dopamine‐beta‐hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex

G. Gessa, R. Frau, G. Flore, 2015, Brain and behavior.

Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex

M. Pistis, G. Gessa, G. Flore, 2020, Frontiers in Pharmacology.

Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease

A. Björklund, M. Carta, P. Devoto, 2014, Experimental Neurology.

Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats.

M. Collu, G. Serra, P. Devoto, 1997, European journal of pharmacology.

Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.

G. Gessa, G. Flore, P. Devoto, 2004, European journal of pharmacology.

Effect of calcium antagonists on [3H]dopamine uptake.

P. Devoto, P. Saba, A. Tagliamonte, 1990, Pharmacological research.

Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons

P. Spano, C. Missale, P. Savoia, 2017, Molecular Neurobiology.

Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation

C. Wellman, S. Scheggi, C. Gambarana, 2019, Neuropharmacology.

Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice

M. Coba, J. Shih, M. Bortolato, 2013, Neuropharmacology.

NMDARs Mediate the Role of Monoamine Oxidase A in Pathological Aggression

A. Urbani, R. Frau, J. Shih, 2012, The Journal of Neuroscience.

Dysfunctional mesocortical dopamine circuit at pre-adolescence is associated to aggressive behavior in MAO-A hypomorphic mice exposed to early life stress

R. Frau, N. Simola, M. Bortolato, 2019, Neuropharmacology.

Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex

G. Gessa, S. Scheggi, C. Gambarana, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction

S. Scheggi, C. Gambarana, M. G. De Montis, 2019, Neurobiology of Disease.

Fasting biases μ-opioid receptors toward β–arrestin2-dependent signaling in the accumbens shell

S. Scheggi, C. Gambarana, P. Devoto, 2017, Neuroscience.

The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease

F. Marrosu, A. Cannas, C. Missale, 2017, Experimental Neurology.

Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release

P. Phillips, D. Jarmolowicz, M. Bortolato, 2017, Neuropharmacology.

Evidence for Immune Activation and Resistance to Glucocorticoids Following Childhood Maltreatment in Adolescents Without Psychopathology

F. Marrosu, M. Puligheddu, S. Scheggi, 2017 .

Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens

A. Urbani, L. Calzetta, P. Roncada, 2016, Psychoneuroendocrinology.

5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model

M. Collu, E. Tronci, M. Carta, 2013, Neurobiology of Disease.

Labetalol blockade of central α- and β-noradrenergic receptors in rat brain homogenates

P. Devoto, R. Collu, E. Stefanini, 1980 .

The dopamine beta‐hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant‐induced dopamine release in the prefrontal cortex

G. Gessa, G. Flore, P. Devoto, 2014, Addiction biology.

Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine.

M. Collu, P. Devoto, A. Vaccari, 1996, Toxicology and applied pharmacology.

NMDA receptor inhibition prevents tolerance to cocaine

C. Gambarana, P. Devoto, G. Giorgi, 1992, Pharmacology Biochemistry and Behavior.

Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long–Evans rats

R. Frau, M. Bortolato, P. Devoto, 2016, British journal of pharmacology.

Positive Allosteric Modulation of GABAB Receptors Ameliorates Sensorimotor Gating in Rodent Models

P. Malherbe, R. Frau, M. Bortolato, 2014, CNS neuroscience & therapeutics.

Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation

F. Marrosu, R. Frau, G. Flore, 2012, Psychoneuroendocrinology.

Levodopa prevents the reinstatement of cocaine self‐administration in rats via potentiation of dopamine release in the medial prefrontal cortex

G. Gessa, W. Fratta, L. Fattore, 2018, Addiction biology.

Dissociation of Haloperidol, Clozapine, and Olanzapine Effects on Electrical Activity of Mesocortical Dopamine Neurons and Dopamine Release in the Prefrontal Cortex

M. Pistis, G. Gessa, G. Flore, 2000, Neuropsychopharmacology.

Maternal Immune Activation Disrupts Dopamine System in the Offspring

M. Pistis, R. Frau, A. Luchicchi, 2016, The international journal of neuropsychopharmacology.

Maternal immune activation disrupts dopamine system in the offspring. Category: Research article Short title: Maternal immune activation and dopamine system.

M. Pistis, R. Frau, A. Luchicchi, 2016 .

Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation

R. Frau, M. Bortolato, P. Devoto, 2014, Psychoneuroendocrinology.

Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice

R. Frau, M. Bortolato, P. Devoto, 2013, Psychoneuroendocrinology.

Serotonin is reduced in the frontal cortex of Sardinian ethanol-preferring rats.

G. Gessa, G. Colombo, P. Devoto, 1998, Alcohol and alcoholism.

Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress

R. Frau, D. Caruso, M. Bortolato, 2015, Schizophrenia Research.

Gating deficits in isolation‐reared rats are correlated with alterations in protein expression in nucleus accumbens

Roberto Frau, Andrea Carpentieri, Alessio Soggiu, 2009, Journal of neurochemistry.

Detection of 3H-cimetidine specific binding in rat anterior pituitary.

E. Carboni, P. Devoto, P. Spano, 1980, European Journal of Pharmacology.

Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study

M. Pistis, L. Ferraro, S. Tanganelli, 2002, Brain Research.

Decreased adenosine A2 receptor function in morphine dependent rats

P. Devoto, P. Saba, M. G. Montis, 1992 .

Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders.

F. Marrosu, R. Frau, M. Bortolato, 2011, Current pharmaceutical design.

The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating

R. Frau, M. Bortolato, P. Devoto, 2016, Psychoneuroendocrinology.

Beta-adrenergic receptor-linked adenylate cyclase in rat posterior pituitary.

P. Devoto, R. Collu, E. Stefanini, 1980, Life sciences.

Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal

G. Gessa, G. Flore, M. Diana, 2002, Psychopharmacology.

Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex

G. Gessa, M. Fà, G. Flore, 2005, Journal of neurochemistry.

Selective adenylate cyclase increase in the limbic area of long-term imipramine-treated rats.

G. Gessa, G. Serra, P. Devoto, 1990, European journal of pharmacology.

[3H]Spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland.

P. Devoto, R. Collu, E. Stefanini, 1980, Life sciences.

Possible antidepressant activity of methadone.

P. Devoto, A. Tagliamonte, G. D. De Montis, 1982, European journal of pharmacology.

6‐Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex

G. Gessa, G. Flore, M. P. Castelli, 2008, Journal of neuroscience research.

Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic

G. Gessa, M. Casu, G. Flore, 2003, Psychopharmacology.

The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.

V. Russell, R. Oades, T. Sagvolden, 2005, Developmental science.

Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone

I. Katona, J. Cheer, R. Frau, 2019, Nature Neuroscience.

Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.

M. Pistis, L. Ferraro, S. Tanganelli, 2002, Brain research.

Ethanol, at micromolar concentrations, increases the affinity of [3H]MK-801 binding in rat brain.

G. Gessa, P. Devoto, G. Giorgi, 1991, European journal of pharmacology.

Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats

R. Frau, M. Bortolato, Yijun Fan, 2014, European Neuropsychopharmacology.

The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients

P. Calabresi, Qin Li, E. Bézard, 2019, Scientific Reports.

Sodium-dependent interaction of benzamides with dopamine receptors in rat and dog anterior pituitary glands.

P. Devoto, R. Collu, E. Stefanini, 1981, Neuroendocrinology.

Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex

G. Flore, G. Gessa, P. Devoto, 2001, Molecular Psychiatry.

Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation

G. Gessa, R. Frau, W. Fratta, 2016, Addiction biology.

Chronic imipramine reduces [3H]SCH 23390 binding and DA-sensitive adenylate cyclase in the limbic system.

G. Gessa, G. Serra, P. Devoto, 1989, European journal of pharmacology.

Alpha2‐adrenoceptor mediated co‐release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex

G. Gessa, G. Flore, P. Devoto, 2004, Journal of neurochemistry.

Dopamine and Noradrenaline Coupling in the Cerebral Cortex

G. Flore, P. Devoto, 2007 .

Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals

M. Pistis, P. Devoto, C. Sagheddu, 2023, Frontiers in pharmacology.

Effect of ethanol on extracellular 5-hydroxytryptamine output in rat frontal cortex.

G. Gessa, C. Portas, P. Devoto, 1994, European journal of pharmacology.

Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long–Evans rats

R. Frau, M. Bortolato, P. Devoto, 2016, British journal of pharmacology.

Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity

P. Devoto, A. Tagliamonte, G. Montis, 1987, Journal of neuroscience research.